John Woolford
VP & Head of Corporate DevelopmentMr. John Woolford is VP & Head of Corporate Development of Eloxx Pharmaceuticals, Inc. Mr. Woolford serves as Managing Director at Westwicke Partners, LLC. He previously served at Legg Mason Wood Walker, Inc., Research Division. Previously, Mr. Woolford was a Life Sciences Equity Research analyst at Legg Mason Wood Walker, Inc., now part of Stifel Nicolaus. He began his career in operational roles at Primedica Corporation, now a subsidiary of Charles River Labs and MedImmune, Inc., now a subsidiary of AstraZeneca International. Most recently, Mr. Woolford was Director of Finance and Strategic Planning at Lentigen Corporation, a venture-stage biotechnology company, with responsibility for corporate positioning, strategy and capital raising. He previously served as Director of Business Planning at Opus Bio, Inc. Mr. Woolford received an MBA from the R.H. Smith School of Business and a BS degree in Microbiology from the University of Maryland at College Park.
Positions
- Company NameEloxx Pharmaceuticals, Inc.Stock CodeELOXPositionVP & Head of Corporate DevelopmentColleagues
- SASumit AggarwalPresident, CEO & Director
- AEAlan Edmund WaltsIndependent Chairman
- DEDaniel E. GeffkenInterim Chief Financial Officer
- RCRoger ClarkVP & Head of Discovery Sciences
- TSTeji SinghVP & Head of Clinical Development
- SDSteven D. RubinIndependent Director
- DBDavid BedwellMember of Scientific Advisory Board
- RGRachel GreenMember of Scientific Advisory Board
